Point72 Asset Management
AXSM icon

Point72 Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Point72 Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.42M Buy
+34,400
New +$7.46M 0.01% 1394
2026
Q1 		– Sell
-4,400
Closed -$804K – 3780
2025
Q4 		$804K Hold
4,400
– – ﹤0.01% 2993
2025
Q3 		$534K Hold
4,400
– – ﹤0.01% 1898
2025
Q2 		$459K Sell
4,400
-200
-4% -$21.2K ﹤0.01% 1814
2025
Q1 		$536K Buy
+4,600
New +$524K ﹤0.01% 1615
2024
Q4 		– Sell
-10,900
Closed -$980K – 2079
2024
Q3 		$980K Hold
10,900
– – ﹤0.01% 1424
2024
Q2 		$877K Buy
10,900
+2,500
+30% +$185K ﹤0.01% 1304
2024
Q1 		$670K Buy
+8,400
New +$705K ﹤0.01% 1564

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Point72 Asset Management's AXSM Position: Q2 2026 in Review

Point72 Asset Management reduced its Axsome Therapeutics (AXSM) stake by 1.9% in Q2 2026, selling an estimated $1.79M and leaving 416,516 shares worth $102M. The position accounts for 0.11% of the portfolio, ranked #199.

Point72 Asset Management first reported a position in AXSM in Q4 2018 and has held it in 24 quarters since. 505 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Point72 Asset Management held 416,516 shares of Axsome Therapeutics worth $102M as of Q2 2026.
  • Point72 Asset Management sold 8,234 Axsome Therapeutics shares in Q2 2026, an estimated $1.79M.
  • Axsome Therapeutics made up 0.11% of Point72 Asset Management's portfolio in Q2 2026, its #199 holding.
  • Point72 Asset Management first reported a position in Axsome Therapeutics in Q4 2018 and has held it in 24 quarters since.
  • 505 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.